0

GR203040

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP168398025
CAS168398-02-5
Molecular Weight437.37
Description≥98% (HPLC)
SolubilityH2O: 10 mg/mL, clear (warmed)
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

(2 S,3 S)-(2-[ 11 C]Methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine

Kenneth T. Cheng

PMID: 20641510

1

Brain Uptake and Receptor Binding of Two [11C]labelled Selective High Affinity NK1-antagonists, GR203040 and GR205171--PET Studies in Rhesus Monkey

M Bergström, K J Fasth, G Kilpatrick, P Ward, K M Cable, M D Wipperman, D R Sutherland, B Långström

Neuropharmacology. 2000 Feb 14;39(4):664-70.

PMID: 10728887

1

GR205171: A Novel Antagonist With High Affinity for the Tachykinin NK1 Receptor, and Potent Broad-Spectrum Anti-Emetic Activity

C J Gardner, D R Armour, D T Beattie, J D Gale, A B Hawcock, G J Kilpatrick, D J Twissell, P Ward

Regul Pept. 1996 Aug 27;65(1):45-53.

PMID: 8876035

1

The Broad-Spectrum Anti-Emetic Activity of the Novel Non-Peptide Tachykinin NK1 Receptor Antagonist GR203040

C J Gardner, D J Twissell, T J Dale, J D Gale, C C Jordan, G J Kilpatrick, C Bountra, P Ward

Br J Pharmacol. 1995 Dec;116(8):3158-63.

PMID: 8719790

1

The Pharmacology of GR203040, a Novel, Potent and Selective Non-Peptide Tachykinin NK1 Receptor Antagonist

D T Beattie, I J Beresford, H E Connor, F H Marshall, A B Hawcock, R M Hagan, J Bowers, P J Birch, P Ward

Br J Pharmacol. 1995 Dec;116(8):3149-57.

PMID: 8719789

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode